ITRM20030178A1 - Uso della l-carnitina per il trattamento di patologie cardiovascolari. - Google Patents

Uso della l-carnitina per il trattamento di patologie cardiovascolari.

Info

Publication number
ITRM20030178A1
ITRM20030178A1 IT000178A ITRM20030178A ITRM20030178A1 IT RM20030178 A1 ITRM20030178 A1 IT RM20030178A1 IT 000178 A IT000178 A IT 000178A IT RM20030178 A ITRM20030178 A IT RM20030178A IT RM20030178 A1 ITRM20030178 A1 IT RM20030178A1
Authority
IT
Italy
Prior art keywords
carnitine
treatment
cardiovascular diseases
cardiovascular
diseases
Prior art date
Application number
IT000178A
Other languages
English (en)
Italian (it)
Inventor
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000178A priority Critical patent/ITRM20030178A1/it
Publication of ITRM20030178A0 publication Critical patent/ITRM20030178A0/it
Priority to CNA2004800015143A priority patent/CN1717232A/zh
Priority to KR1020057013711A priority patent/KR20050121196A/ko
Priority to AU2004229256A priority patent/AU2004229256A1/en
Priority to PCT/IT2004/000107 priority patent/WO2004091602A1/en
Priority to BR0406552-2A priority patent/BRPI0406552A/pt
Priority to EP04716692A priority patent/EP1613301A1/en
Priority to JP2006507635A priority patent/JP2006523685A/ja
Priority to CNA2008101490996A priority patent/CN101467992A/zh
Priority to MXPA05007612A priority patent/MXPA05007612A/es
Priority to CA002508636A priority patent/CA2508636A1/en
Priority to US10/538,868 priority patent/US20060052450A1/en
Publication of ITRM20030178A1 publication Critical patent/ITRM20030178A1/it
Priority to US12/232,321 priority patent/US20090042983A1/en
Priority to AU2010202396A priority patent/AU2010202396A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000178A 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari. ITRM20030178A1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT000178A ITRM20030178A1 (it) 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US10/538,868 US20060052450A1 (en) 2003-04-17 2004-03-03 Use of l-carnitine for the treatment of cardiovascular diseases
EP04716692A EP1613301A1 (en) 2003-04-17 2004-03-03 Use of l-carnitine for the treatment of cardiovascular diseases
CNA2008101490996A CN101467992A (zh) 2003-04-17 2004-03-03 L-肉碱用于治疗心血管疾病的用途
AU2004229256A AU2004229256A1 (en) 2003-04-17 2004-03-03 Use of L-carnitine for the treatment of cardiovascular diseases
PCT/IT2004/000107 WO2004091602A1 (en) 2003-04-17 2004-03-03 Use of l-carnitine for the treatment of cardiovascular diseases
BR0406552-2A BRPI0406552A (pt) 2003-04-17 2004-03-03 Uso de l-carnitina para o tratamento de doenças cardiovasculares
CNA2004800015143A CN1717232A (zh) 2003-04-17 2004-03-03 L－肉碱用于治疗心血管疾病的用途
JP2006507635A JP2006523685A (ja) 2003-04-17 2004-03-03 循環器疾患の治療のためのｌ−カルニチンの使用
KR1020057013711A KR20050121196A (ko) 2003-04-17 2004-03-03 심혈관 질환의 치료를 위한 ｌ―카르니틴의 용도
MXPA05007612A MXPA05007612A (es) 2003-04-17 2004-03-03 Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares.
CA002508636A CA2508636A1 (en) 2003-04-17 2004-03-03 Use of l-carnitine for the treatment of cardiovascular diseases
US12/232,321 US20090042983A1 (en) 2003-04-17 2008-09-15 Use of L-carnitine for the treatment of cardiovascular diseases
AU2010202396A AU2010202396A1 (en) 2003-04-17 2010-06-14 Use of L-carnitine for the treatment of cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000178A ITRM20030178A1 (it) 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari.

Publications (2)

Publication Number Publication Date
ITRM20030178A0 ITRM20030178A0 (it) 2003-04-17
ITRM20030178A1 true ITRM20030178A1 (it) 2004-10-18

Family

ID=29765768

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000178A ITRM20030178A1 (it) 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari.

Country Status (11)

Country Link
US (1) US20060052450A1 (enExample)
EP (1) EP1613301A1 (enExample)
JP (1) JP2006523685A (enExample)
KR (1) KR20050121196A (enExample)
CN (2) CN101467992A (enExample)
AU (2) AU2004229256A1 (enExample)
BR (1) BRPI0406552A (enExample)
CA (1) CA2508636A1 (enExample)
IT (1) ITRM20030178A1 (enExample)
MX (1) MXPA05007612A (enExample)
WO (1) WO2004091602A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20070260674A1 (en) * 2006-05-02 2007-11-08 Research In Motion Limited Push framework for delivery of dynamic mobile content
EP2268304A2 (en) * 2008-03-26 2011-01-05 Orthologic Corp. Methods for treating acute myocardial infarction
EP2353596A1 (en) 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2012150146A1 (en) 2011-05-03 2012-11-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition useful for the treatment of lipid metabolism disorders
CN114073705A (zh) * 2020-08-14 2022-02-22 常州高新技术产业开发区三维工业技术研究所有限公司 一种降尿酸药物组合物及其应用
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS531812B2 (enExample) * 1972-12-07 1978-01-23
WO2000030637A1 (en) * 1998-11-26 2000-06-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia

Also Published As

Publication number Publication date
CA2508636A1 (en) 2004-10-28
EP1613301A1 (en) 2006-01-11
ITRM20030178A0 (it) 2003-04-17
AU2010202396A1 (en) 2010-07-01
KR20050121196A (ko) 2005-12-26
MXPA05007612A (es) 2005-09-30
US20060052450A1 (en) 2006-03-09
AU2004229256A1 (en) 2004-10-28
CN1717232A (zh) 2006-01-04
WO2004091602A1 (en) 2004-10-28
JP2006523685A (ja) 2006-10-19
BRPI0406552A (pt) 2005-12-20
CN101467992A (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
NO20052058D0 (no) Behandling av influensa.
EP1500371A4 (en) ULTRASOUND DEVICE
EP1665987A4 (en) ULTRASOUND DEVICE
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
DK1597171T3 (da) Terapeutisk mikroskum
ITRM20030178A1 (it) Uso della l-carnitina per il trattamento di patologie cardiovascolari.
DE502004005544D1 (de) Mikrodosiereinrichtung
ITRM20010708A0 (it) Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
DE602004030779D1 (de) Angehen des problems des schrittmachersyndroms
FR2837224B1 (fr) Bonde traitante
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ITRM20020492A1 (it) Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
NO20053189D0 (no) HVC-kombinasjonsterapi.
NO20022747D0 (no) Behandlingsstol
ITVE20020040A1 (it) Procedimento di trattamento delle pelli. -
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
ITMI20022263A1 (it) Composizioni per il trattamento delle emorroidi.
ITMI20030492A1 (it) Composizioni per il trattamento della sindrome premestruale.
ITMI20021205A0 (it) Uso di proteine per il trattamento della leishmaniosi
ITTO20020465A0 (it) Procedimento per la preparazione di doxofillina.
ITMI20020620A0 (it) Procedimento per la preparazione di alchil-benzoati per esterificazione di benzoil-fluoruri
FI20020356A0 (fi) Sauna
ITMI20041061A1 (it) Procedimento per la preparazione della 3,5-bis trifluyorometil anilina
ITMO20020183A0 (it) Preparato per trattamenti di perdermostimolazione